Alpha Teknova, Inc. (NASDAQ:TKNO) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Alpha Teknova, Inc. (NASDAQ:TKNO) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
To the annoyance of some shareholders, Alpha Teknova, Inc. (NASDAQ:TKNO) shares are down a considerable 25% in the last month, which continues a horrid run for the company. The recent drop has obliterated the annual return, with the share price now down 9.1% over that longer period.
Since its price has dipped substantially, Alpha Teknova may be sending bullish signals at the moment with its price-to-sales (or "P/S") ratio of 2x, since almost half of all companies in the Life Sciences industry in the United States have P/S ratios greater than 3.4x and even P/S higher than 7x are not unusual. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.
NasdaqGM:TKNO Price to Sales Ratio vs Industry April 24th 2024
How Alpha Teknova Has Been Performing
With revenue that's retreating more than the industry's average of late, Alpha Teknova has been very sluggish. Perhaps the market isn't expecting future revenue performance to improve, which has kept the P/S suppressed. If you still like the company, you'd want its revenue trajectory to turn around before making any decisions. Or at the very least, you'd be hoping the revenue slide doesn't get any worse if your plan is to pick up some stock while it's out of favour.
Keen to find out how analysts think Alpha Teknova's future stacks up against the industry? In that case, our free report is a great place to start.
How Is Alpha Teknova's Revenue Growth Trending?
Alpha Teknova's P/S ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the industry.
In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 11%. That put a dampener on the good run it was having over the longer-term as its three-year revenue growth is still a noteworthy 17% in total. Although it's been a bumpy ride, it's still fair to say the revenue growth recently has been mostly respectable for the company.
Shifting to the future, estimates from the five analysts covering the company suggest revenue should grow by 36% per annum over the next three years. That's shaping up to be materially higher than the 6.5% each year growth forecast for the broader industry.
In light of this, it's peculiar that Alpha Teknova's P/S sits below the majority of other companies. Apparently some shareholders are doubtful of the forecasts and have been accepting significantly lower selling prices.
What We Can Learn From Alpha Teknova's P/S?
Alpha Teknova's P/S has taken a dip along with its share price. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.
A look at Alpha Teknova's revenues reveals that, despite glowing future growth forecasts, its P/S is much lower than we'd expect. There could be some major risk factors that are placing downward pressure on the P/S ratio. While the possibility of the share price plunging seems unlikely due to the high growth forecasted for the company, the market does appear to have some hesitation.
There are also other vital risk factors to consider before investing and we've discovered 4 warning signs for Alpha Teknova that you should be aware of.
Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
令一些股東惱火的是,Alpha Teknova, Inc.(納斯達克股票代碼:TKNO)的股價在過去一個月裏下跌了25%,延續了該公司糟糕的走勢。 最近的下跌抹殺了年回報率,在這段較長的時間內,股價下跌了9.1%。
由於其價格大幅下跌,Alpha Teknova目前可能正在發出看漲信號,其市銷率(或 “市盈率”)爲2倍,因爲美國生命科學行業幾乎有一半的公司市盈率大於3.4倍,即使市盈率高於7倍也並不少見。但是,僅按面值計算市銷率是不明智的,因爲可以解釋其有限的原因。
納斯達克通用汽車公司:TKNO 與行業的股價銷售比率 2024 年 4 月 24 日
Alpha Teknova 的表現如何
由於收入的下降幅度超過了該行業的平均水平,Alpha Teknova一直表現不佳。也許市場預計未來的收入表現不會改善,這使市銷率一直受到抑制。如果你仍然喜歡這家公司,那麼在做出任何決定之前,你希望其收入軌跡得到扭轉。或者至少,如果你的計劃是在失寵的時候買入一些股票,你希望收入下滑不會變得更糟。
想了解分析師如何看待Alpha Teknova的未來與該行業的對立嗎?在這種情況下,我們的免費報告是一個很好的起點。
Alpha Teknova 的收入增長趨勢如何?
Alpha Teknova的市銷率對於一家預計增長有限,而且重要的是表現不如行業的公司來說是典型的。
在回顧去年的財務狀況時,我們沮喪地看到該公司的收入下降至11%左右。這抑制了其長期的良好表現,因爲其三年總收入增長仍爲17%,值得注意的是。儘管這是一個坎坷的旅程,但可以公平地說,該公司最近的收入增長基本上是可觀的。
展望未來,報道該公司的五位分析師的估計表明,未來三年收入將每年增長36%。這將大大高於整個行業每年6.5%的增長預期。
有鑑於此,奇怪的是,Alpha Teknova的市銷率低於其他多數公司。顯然,一些股東對預測持懷疑態度,並一直在接受大幅降低的銷售價格。
我們可以從 Alpha Teknova 的市銷率中學到什麼?
Alpha Teknova的市銷率與股價一起下跌。儘管市銷率不應該成爲決定你是否買入股票的決定性因素,但它是衡量收入預期的有力晴雨表。
看看Alpha Teknova的收入就會發現,儘管對未來的增長預測很高,但其市銷率遠低於我們的預期。可能有一些主要的風險因素給市銷率帶來下行壓力。儘管由於預計該公司將實現高增長,股價暴跌的可能性似乎不大,但市場似乎確實有些猶豫。
在投資之前,還有其他重要的風險因素需要考慮,我們發現了Alpha Teknova的4個警告信號,你應該注意這些信號。
當然,具有良好收益增長曆史的盈利公司通常是更安全的選擇。因此,您可能希望看到這些免費收集的市盈率合理且收益增長強勁的其他公司。
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧